| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |